2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Receptors, Dopamine D1
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.
Receptors, Dopamine D2
Receptors, Dopamine
Hydroxycholecalciferols
Dopamine
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Ricinoleic Acids
Calcitriol
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
Taurodeoxycholic Acid
Leukotriene A4
(2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990)
Dose-Response Relationship, Drug
Rats, Sprague-Dawley
Glycodeoxycholic Acid
Deoxycholic Acid
Chenodeoxycholic Acid
Arachidonate Lipoxygenases
Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- .
Hydroxylation
Taurocholic Acid
Receptors, Calcitriol
Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA with the participation of D receptor interacting proteins (called DRIP). Vitamin D is converted in the liver and kidney to calcitriol and ultimately acts through these receptors.
Stereoisomerism
Chromatography, Thin Layer
Chromatography, High Pressure Liquid
Hydro-Lyases
Chromatography, Gas
Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.
Mass Spectrometry
Molecular Structure
Ursodeoxycholic Acid
Structure-Activity Relationship
Cholic Acids
Gas Chromatography-Mass Spectrometry
Isoleucine
Bile
Lipoxygenase
Biotransformation
The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
Magnetic Resonance Spectroscopy
Mixed Function Oxygenases
Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation.
Vitamin D Deficiency
A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)
Taurine
Intestine, Small
Oxidation-Reduction
A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471).
Biological Transport, Active
Vitamin D
A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
Cytochrome P-450 Enzyme System
A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.
Microsomes, Liver
Liver
Calcium
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Fatty Acids
Species Specificity
The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.
Cholesterol
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Cells, Cultured
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
Phenylacetates
Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID.
6-Br-APB
47 Suppl 1: 256-73. doi:10.1016/j.neuropharm.2004.07.007. PMID 15464142. v t e (CS1: long volume value, Articles with short ... December 1991). "(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 ... 275 (3): 1367-74. PMID 8531104. Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004). "Effects of dopamine indirect agonists and ... 116 (1): 9-18. doi:10.1007/BF02244865. PMID 7862937. Weed MR, Woolverton WL (December 1995). "The reinforcing effects of ...
List of MeSH codes (D03)
... phenyl)-1h-pyrazol-3-amine MeSH D03.383.129.539.200 - epirizole MeSH D03.383.129.539.487 - indazoles MeSH D03.383.129.539. ... phenyl)-, methyl ester MeSH D03.383.725.547.950 - xanthinol niacinate MeSH D03.383.725.565 - nicotinyl alcohol MeSH D03.383. ... phenyl)-, methyl ester MeSH D03.383.725.210 - dimethindene MeSH D03.383.725.220 - 2,2'-dipyridyl MeSH D03.383.725.227 - ... 2,3,4,5-tetrahydro-8-chloro-3-methyl-5-phenyl-1h-3-benzazepin-7-ol MeSH D03.438.079.800 - 2,3,4,5-tetrahydro-7,8-dihydroxy-1- ...
Dopamine receptor D1
Some of the benzazepines have high intrinsic activity whereas others do not. In 2015 the first positive allosteric modulator ... 1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human ... 12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new ... Benzazepine derivatives SCH-23,390 - 100-fold selectivity for D1 over D5 Ecopipam (SCH-39,166) - a selective D1/D5 antagonist ...
Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey<...
The D2 DA receptor agonist R-(-)-Propylnorapomorphine HCl inhibited VIP-induced PRL secretion at the level of the anterior ... 5, 30.11.1998, p. 319-325.. Research output: Contribution to journal › Article › peer-review ... 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine Medicine & Life Sciences 10% ... DA effected this blockade of PRL via D2 DA receptors residing within the anterior pituitary. The data also suggested that there ...
MH DELETED MN ADDED MN
Benzazepines D3.438.79 D3.633.100.79 Benzbromarone D3.438.127.110 D3.633.100.127.110 Benzimidazoles D3.438.103 D3.633.100.103 ... ELAV-Like Protein 2 D12.776.641.520.500 D12.776.631.520.500 ELAV-Like Protein 3 D12.776.641.520.750 D12.776.631.520.750 ELAV- ... Heterocyclic Compounds with 4 or More Rings D3.549 D3.633.400 (Replaced for 2016 by Heterocyclic Compounds, 4 or More Rings) ... 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine D3.438.79.800 D3.633.100.79.800 2-Aminopurine D3.438.759.138.50 ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
DeCS 2005 - Changed terms
... phenyl)-1H-pyrazol-3-amine. Ro 20-1724. 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. ... Ro 4-1284. 2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-. ... Pregnancy-Specific beta 1-Glycoprotein. Pregnancy-Specific beta 1-Glycoproteins. Tissue Inhibitor of-Metalloproteinase-3. ... trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride. BW 284 C 51. Benzenaminium, 4,4-(3-oxo-1,5-pentanediyl)bis( ...
IMSEAR at SEARO: On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
Benzazepines --pharmacology. en_US. dc.subject.mesh. Desipramine --pharmacology. en_US. dc.subject.mesh. Dioxanes -- ... SCH 23390 (10(-5) M), a D1 DA antagonist potentiated the response to DA. Reserpinization (5 mg/kg, 24 hr prior) brought about a ... Alpha 2 antagonists yohimbine (10(-5) M) and idazoxan (10(-5) M) blocked the response to DA in a competitive manner, while ... Desipramine (10(-5) M) blocked the response of DA in a non-competitive manner. Pretreatment of animals with desipramine (10 mg/ ...
Pesquisa | Biblioteca Virtual em Saúde - BRASIL
3. Reversed Phase SPE and GC-MS Study of Polycyclic Aromatic Hydrocarbons in Water Samples from the River Buriganga, Bangladesh ... 8. Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and ... 2. Identifying influence of perceived quality and satisfaction on the utilization status of the community clinic services; ... 2,3,4,5-Tetra-Hidro-7,8-Di-Hidroxi-1-Fenil-1H-3-Benzazepina/farmacologia , Benzazepinas/farmacologia , Hipocampo/efeitos dos ...
GLASS ID: 160039
RS(+/-)SKF 383931-Phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol. SKF 38393-A. (A+/-)-SKF-38393 hydrochloride. 1H-3- ... 1H-3-Benzazepine-7,8-diol,2,3,4,5-tetrahydro-1-phenyl-, hydrochloride (1:1). BRD-A88548664-001-02-3. Lopac0_000436. PDSP1_ ... Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-. 67287-49-4. BPBio1_001229. CHEBI:131801. L000563. NCGC00024875-04. SK&F- ... 6-PHENYL-4-AZOBICYCLO[5.4.0]UNDECA-7,9,11-TRIENE-9,10-DIOL. Biomol-NT_000034. CHEBI:110200. KS-00001CZ8 ...
103-78-6: 1-Cyclohexylacetone - Veeprho
N-Phenyl-N-cyclohexyl-p-phenylenediamine. VE008618. View CAS 101-87-1. ... Tetrahydro-2H-pyran-2-ol. VE005933. View CAS 694-54-2. Tetrahydrofuroic acid. VE006494. View CAS 16874-33-2. ... 1H)-one. VE0010400. View CAS 14548-50-6. 7-Methoxy-1H-indole-3-carbaldehyde. VL3850086. View CAS 109021-59-2. ... 2 years. This cookie is installed by Google Analytics.. _gat_UA-152546504-1. 1 minute. A variation of the _gat cookie set by ...
N-(2,4-dioxo-1-imidazolidinyl)benzamide - C10H9N3O3, density, melting point, boiling point, structural formula, synthesis
2,4-dioxo-1-imidazolidinyl)benzamide - C10H9N3O3, synthesis, structure, density, melting point, boiling point ... Tags: melting point of N-(2,4-dioxo-1-imidazolidinyl)benzamide , boiling point of N-(2,4-dioxo-1-imidazolidinyl)benzamide , ... density of N-(2,4-dioxo-1-imidazolidinyl)benzamide , refractive index of N-(2,4-dioxo-1-imidazolidinyl)benzamide ... 2-tert-butyl-5-methyl-1,3,4,7,11c-pentaazabenzo[de]anthracene ... 4-amino-5-thiazol-2-yl-1H-pyrimidin-2-one *4-amino-5-pyridin-2- ...
5 molecular information - Cas Number Lookup | Chemical Cas No Search for Molecular info (Name,Formula And structure)
8A-tetrahydro, Wln: L66 bv ev cu hutj, 1-Bromo-3-methoxy-6-oxo-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepine-11 ... 6r-dihydroxy-7e,9e,11z,14z-eicosatetraenoic acid, (5S,6R,7E,9E,11Z,14Z)-5,6-Dihydroxy-7,9,11,14-icosatetraenoic acid, 7,9,11,14 ... phenyl]acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Formula:C20H22N4O4S Synonyms:(6r,7r)-3-methyl-8-oxo- ... benzazepine-11(12H)-carbaldehyde Formula:C17H16BrNO4 Synonyms:4a,5,5,8a-tetrahydro-1,4-naphthoquinone, 6H-Benzofuro[3a,3,2-ef][ ...
CHEMOS GmbH & Co. KG @ ChemBuyersGuide.com, Inc.
PHENYL]METHYL]-1H-CARBAZOLE-1-ACETIC ACID. CAS:121083-05-4 ... 3R,7AS)-TETRAHYDRO-3-PHENYL-3H,5H-PYRROLO[1,2-C]OXAOLE-5-ONE. ... TRANS-10,11-DIHYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINE HYDROCHLORIDE. CAS:123039-93-0 ... BENZAZEPINE MALEATE (1:1). CAS:85650-53-9 ( )-1,2,3,4,4A,9-HEXAHYDRO-2-METHYLDIBENZO[C,F]PYRIMIDO[1,6-A]AZEPINE. CAS:85750-26-1 ... 11-?9-TETRAHYDRO CANNABINOL-9-METHANOL. CAS:36557-05-8 (-)-2,2-ISOPROPYLIDENEBIS[(4S)-4-PHENYL-2-OXAZOLINE], 97%. CAS:131457- ...